IOVANCE BIOTHERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 120966000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2016-06-30) |
| Status | current |
| Entity | IOVANCE BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:00:07.394839+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/02879d17-1593-405d-b273-57ecb242d3f8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-17-040380Retrieved: 2026-08-19T14:00:07.394839+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001425205/cash-and-equivalents/2016-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/02879d17-1593-405d-b273-57ecb242d3f8
History
- supersedes {"amount": 101222000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001144204-16-117596)